MEMORANDUM OPINION
Denying the Defendant’s Motion to Transfer
I. INTRODUCTION
Today the court denies a motion to transfer. Eli Lilly & Co., one of three *125 remaining defendants, moves to transfer this suit to the District of Massachusetts on the grounds that the District of Columbia is an inconvenient forum for the litigation of this products liability action for the manufacture, distribution and sale of Diethystilbestrol (“DES”). 1 The plaintiffs, Elizabeth Mahoney and Alicia Benting (sisters exposed in útero to DES) and Richard Benting (Alicia’s husband), oppose transfer. Noting the lateness of the request, the near conclusion of discovery, and the familiarity of this court with DES litigation, they submit that an improper motive of delay provides the impetus behind the defendant’s request. The defendant insists that it merely seeks to ensure that the law is applied by the forum most closely connected to the facts of the case. Had the defendant sought transfer sooner, the court might agree. But at this stage of the case, the balance of equities does not favor a transfer because the prejudice to private interests in maintaining the case here is negligible, as is the prejudice to public interests in light of this District’s growing familiarity with DES litigation. The court, therefore, denies the motion.
II. BACKGROUND
A. Factual History
The plaintiff sisters allege that their mother ingested DES during her pregnancies in the late 1960s, resulting in their in útero exposure to the drug, the side effects of which have caused them injuries including uterine and cervical malformations, infertility, ectopic pregnancy, medical expenses and physical and mental pain and suffering. Compl. ¶¶ 4-5, 27-28. Plaintiff Richard Benting alleges that his wife’s above injuries have deprived him of her love, services and affection. Id. ¶ 50. The plaintiffs seek compensatory and punitive damages. Id. at 11-12.
B. Procedural History
On October 27, 2006, the plaintiffs filed an 11-count complaint alleging negligence, strict liability, breach of warranty, misrepresentation, and loss of consortium in the Superior Court of the District of Columbia. Eli Lilly filed a notice of removal on the basis of diversity to the United States District Court for the District of Columbia on November 30, 2006. On August 27, 2007, the parties appeared for an initial status hearing, at which time the court referred the case to Magistrate Judge Kay for settlement discussions and pretrial discovery matters. Min. Order (Aug. 27, 2007). The court also entered a scheduling order setting the close of discovery for March 24, 2008. Id. The plaintiffs responded to Eli Lilly’s preliminary discovery requests on October 4, 2007. Pls.’ Opp’n to Def.’s Mot. to Transfer (“Pls.’ Opp’n”) at 1; Def.’s Mot., Ex. 1. Eli Lilly filed its motion to transfer five months later on March 14, 2008.
III. ANALYSIS
A. Legal Standard for Transfer Pursuant to 28 U.S.C.
§ 1404(a)
When federal jurisdiction is premised solely on diversity, 28 U.S.C. § 1391(a) controls venue, establishing that venue is proper in:
(1) a judicial district where any defendant resides, if all defendants reside in the same State, (2) a judicial district in which a substantial part of the events or omissions giving rise to the claim occurred, or a substantial part of property that is the subject of the action is situated, or (3) a judicial district in which any *126 defendant is subject to personal jurisdiction at the time the action is commenced, if there is no district in which the action may otherwise be brought.
28 U.S.C. § 1391(a).
In an action where venue is proper, 28 U.S.C. § 1404(a) nonetheless authorizes a court to transfer a civil action to any other district where it could have been brought “for the convenience of parties and witnesses, in the interest of justice!.]” 28 U.S.C. § 1404(a). Section 1404(a) vests “discretion in the district court to adjudicate motions to transfer according to [an] individualized, case-by-case consideration of convenience and fairness.”
Stewart Org., Inc. v. Ricoh Corp.,
Accordingly, the defendant must make two showings to justify transfer. First, the defendant must establish that the plaintiff originally could have brought the action in the proposed transferee district.
Van Dusen,
B. The Court Denies the Defendant’s Motion To Transfer
1. The Private-Interest Considerations Do Not Favor Transfer 2
The defendant insists that the plaintiffs’ choice of forum is entitled to little deference because they have not adequately demonstrated a nexus between the District of Columbia and their cause of action. Def.’s Mot. at 6. None of the parties reside in D.C., and none of the events concerning the plaintiffs’ alleged injuries occurred in D.C. Id. at 7. The plaintiffs dissent, observing that the defendants sought regulatory approval for and began their industry- *127 wide promotion of DES in D.C. Pls.’ Opp’n at 5. They intend to seek discovery of the defendants’ lobbyists and salespeople residing in D.C. Id. Moreover, the number of DES cases already decided in this District attenuates any potential benefits of a transfer. Id.
The court agrees with the defendant that the plaintiffs’ choice of forum deserves little deference — but the defendant’s choice deserves no more. While the plaintiffs’ exposure to DES occurred in Massachusetts, the defendant’s lobbying and regulatory campaigns in furtherance of the marketing and distribution of the drug occurred in D.C. Pis.’ Opp’n at 5. Although this may not establish a nexus to D.C. so critical to the core of the plaintiffs’ claim as to warrant deference,
see Boers v. United States,
Turning to the defendants’ choice of forum, obviously Eli Lilly prefers a transfer. However, they have waited some considerable time before making their preference known. Eli Lilly explains that it only waited to confirm the facts through depositions, which the plaintiffs delayed. Defi’s Reply at 4. But Eli Lilly does not explain why this delay was warranted when the pertinent facts had never been placed in doubt. Moreover, Eli Lilly’s co-defendants appear indifferent to the issue. While Lannett has indicated its consent to transfer, it does not join Eli Lilly in the motion. And Bristol-Myers Squibb has not bothered to declare its position. The court, therefore, concludes that this factor only weakly, if at all, supports transfer.
The plaintiffs’ claim arose in Massachusetts where the
in útero
exposure occurred and the Bentings make their marital bed. This factor favors the defendant. However, the defendant has not convincingly explained how continuing the prosecution of this case in D.C. inconveniences any of the parties. The defendant submits that the majority of potential fact and expert witnesses and sources of proof are located in Massachusetts but are not subject to the subpoena power of this court. Def.’s Mot. at 4-5. But the convenience of witnesses “is considered only to the extent that the witnesses may actually be unavailable for trial in one of the fora.”
Brannen v. Nat’l R.R. Passenger Corp.,
Nor is the location of these witnesses inconvenient to the defendant. The court ordered discovery to commence on August 27, 2007, and to close on March 24, 2008. Min. Order (Aug. 27, 2007). The defendant did not file its motion to transfer until March 14, 2008, ten days before the close of discovery. It gives no satisfactory explanation as to why this motion could not have been brought sooner; why the defendant could not have gleaned the factual predicate for this request either from the complaint filed over a year ago or the plaintiffs’ discovery responses made in October last year; or why proceeding to trial
*128
here will “subject Lilly to the risk of not having all necessary fact and expert witnesses available.” Def.’s Mot. at 6. In any event, Eli Lilly proposes to depose only four of the plaintiffs’ experts and one of her physicians, Def.’s Reply at 3, a fact bearing slantwise on transfer,
Dean v. Eli Lilly & Co.,
Because on balance the private equities of a transfer do not outweigh the private interests of preserving the status quo, the court concludes that a transfer on this basis is inappropriate.
2. The Public-Interest Considerations Do Not Favor Transfer
The defendant proposes that the District of Massachusetts has more familiarity in applying Massachusetts tort law than this District. Def.’s Mot. at 7. Under the District of Columbia’s choice of law rules, the law governing the plaintiffs claims is the law of the state with the most significant relationship to the matters at issue.
Church of Scientology Int’l v. Eli Lilly & Co.,
The defendant also urges the court to recognize as “inequitable” the plaintiffs’ attempt to “saddle the District of Columbia and its resources with the burden of disposing of a case that has no connection whatsoever with [D.C.]” Def.’s Mot. at 8. As mentioned previously, however, the case does have some connection to this District, and the defendant has itself selected this forum to litigate its own claims in the past. Moreover, Magistrate Judge Kay has successfully mediated numerous DES eases, placing into serious question the proposition that this District’s time and resources are being wasted. Pis.’ Opp’n at 8.
In assessing the public interest, the court also must weigh the relative congestion of the calendars of the potential transferee and transferor courts. In support of transfer, the defendant cites to a case in which Judge Huvelle aptly noted that to accept governmental contacts in D.C. as a basis for venue “would amount to an open invitation to litigants to sue private parties in this jurisdiction whenever the ease has some relationship to an agency action.”
In re AT&T Access Charge Litig.,
Finally, the court must consider the local interest in deciding local controversies at home. The defendant correctly observes that Massachusetts has a strong interest in knowing that the tort claims of its citizens are treated “fairly and efficiently.” Def.’s Mot. at 8. However, as the plaintiffs also correctly observe: “ ‘there is nothing uniquely local about DES litigation.’ ” Pls.’ Opp’n at 7 (quoting
Ingram,
As the balance of public interests does not clearly favor the movant, the court declines to transfer the case.
IV. CONCLUSION
For the foregoing reasons, the court denies the defendant’s motion to transfer. An order consistent with this Memorandum Opinion is separately and contemporaneously issued this 22nd day of April, 2008.
Notes
. Co-defendant Lannett consents to a transfer; co-defendant Bristol-Myers Squibb takes no position. Def.'s Mot. to Transfer ("Def.'s Mot.”) at 3.
. The plaintiffs do not contest the uncontroversial conclusion that they could have originally brought this action in the District of Massachusetts. See generally Pls.' Opp’n to Def.’s Mot. to Transfer ("Pls.' Opp’n”). Because complete diversity exists, 28 U.S.C. § 1332; because Massachusetts's long-arm statute extends to torts allegedly committed in Massachusetts, Mass. Gen. Laws ch. 223A, § 3; and because a substantial part of the events occurred in Massachusetts, 28 U.S.C. § 1391(a)(2), the court recognizes that this case could have been brought in the District of Massachusetts.
. The defendant raises a couple of complaints about the plaintiffs' responsiveness to its discovery requests, noting that they have yet to send it their causation expert’s report or make him available for a deposition. Def.’s Reply at 4. A motion to compel (following the procedures set forth in this court's standing order) provides a much simpler, more direct resolution for this dispute than a motion to transfer.
